Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)

Matthew J. Wieduwilt, Wendy Stock, Anjali Advani, Selina Luger, Richard A. Larson, Martin Tallman, Frederick Appelbaum, Mei Jie Zhang, Khalid Bo-Subait, Hai Lin Wang, Vijaya Raj Bhatt, Bhagirathbhai Dholaria, Mary Eapen, Mehdi Hamadani, Omer Jamy, Tim Prestidge, Michael Pulsipher, David Ritchie, David Rizzieri, Akshay SharmaPere Barba, Brenda M. Sandmaier, Marcos de Lima, Partow Kebriaei, Mark Litzow, Wael Saber, Daniel Weisdorf

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

The article requires a correction in the funding/acknowledgement statement used. There is a grant number (OT3HL147741) in the “Acknowledgments” section that needs to be removed. The original publication was updated.

Original languageEnglish (US)
Pages (from-to)2140
Number of pages1
JournalLeukemia
Volume35
Issue number7
DOIs
StatePublished - Jul 2021

Bibliographical note

Publisher Copyright:
Copyright © The Author(s), under exclusive licence to Springer Nature Limited 2021.

PubMed: MeSH publication types

  • Published Erratum

Fingerprint

Dive into the research topics of 'Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)'. Together they form a unique fingerprint.

Cite this